FIELD: medicine.
SUBSTANCE: invention represents composition including Bisoprololum or Metoprolol, or Athenolol, Indapamide, Enalapril maleate and Vinpocetine, and specific additives represented with colloidal silicon dioxide, single-crystal cellulose, corn starch and magnesium stearate.
EFFECT: provides potentiation of antihypertensive action and reduction of by-effects due to that composition contains reduced amount of active components.
4 cl, 4 ex, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICINAL AGENT FOR TREATMENT OF HYPERTENSION OR HIGH BLOOD PRESSURE | 2010 |
|
RU2539382C2 |
| COMBINED MEDICATION FOR TREATMENT OF ARTERIAL HYPERTENSION IN PATIENTS WITH DIABETES MELLITUS | 2012 |
|
RU2558099C2 |
| ORAL PHARMACEUTICAL COMPOSITION OF DIURETICS AND ACE INHIBITOR IN MICRONIZED FORM, DRUG AND ITS APPLICATION | 2012 |
|
RU2618471C2 |
| ENALAPRIL MALEATE-BASE SOLID MEDICINAL FORM | 1997 |
|
RU2140261C1 |
| PHARMACEUTICAL COMPOSITION | 2006 |
|
RU2314099C1 |
| PHARMACEUTICAL COMPOSITION CONTAINING BETA-BLOCKER, CONVERTING ENZYME INHIBITOR AND HYPOTENSIVE AGENT OR NSAID | 2017 |
|
RU2756320C2 |
| COMPOSITION CONTAINING FIXED DOSE OF ANGIOTENSIN-TRANSFORMING ENZYME AND CALCIUM CANAL ANTAGONIST AND METHOD FOR PRODUCING THE COMPOSITION AND TREATING CARDIOVASCULAR DISEASES | 1998 |
|
RU2182002C2 |
| COMBINATION OF DIPEPTIDILPEPTIDASE IV (DPP IV) INHIBITOR AND CARDIOVASCULAR SUBSTANCE | 2003 |
|
RU2336876C2 |
| COMBINED HYPOTENSIVE DRUG | 2010 |
|
RU2444371C1 |
| METHOD FOR TREATMENT OF ARTERIAL HYPERTENSION | 2004 |
|
RU2271197C2 |
